{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:42:27Z","timestamp":1790178147530,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018841","name":"Associazione Italiana Ricerca Alzheimer","doi-asserted-by":"publisher","award":["AGYR2022-Medea"],"award-info":[{"award-number":["AGYR2022-Medea"]}],"id":[{"id":"10.13039\/501100018841","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["National Recovery and Resilience Plan, Investment PE8 \u2013 Project Age-It: \u201cAgeing Well in an Ageing Society\u201d"],"award-info":[{"award-number":["National Recovery and Resilience Plan, Investment PE8 \u2013 Project Age-It: \u201cAgeing Well in an Ageing Society\u201d"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013301","name":"Parkinson's Foundation","doi-asserted-by":"publisher","award":["PF-PRF-934916"],"award-info":[{"award-number":["PF-PRF-934916"]}],"id":[{"id":"10.13039\/100013301","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06148-4","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T13:38:40Z","timestamp":1737985120000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Studying Alzheimer\u2019s disease through an integrative serum metabolomic and lipoproteomic approach"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4038-6596","authenticated-orcid":false,"given":"Alessia","family":"Vignoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico Paolini","family":"Paoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Luchinat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Tenori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucilla","family":"Parnetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"key":"6148_CR1","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.biopsych.2016.02.033","volume":"81","author":"SF Foley","year":"2017","unstructured":"Foley SF, Tansey KE, Caseras X, Lancaster T, Bracht T, Parker G, et al. Multimodal Brain Imaging reveals structural differences in Alzheimer\u2019s Disease Polygenic Risk Carriers: a study in healthy young adults. Biol Psychiatry. 2017;81:154\u201361.","journal-title":"Biol Psychiatry"},{"key":"6148_CR2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2011;7:280\u201392.","journal-title":"Alzheimer\u2019s Dement"},{"key":"6148_CR3","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s40120-022-00338-8","volume":"11","author":"AA Tahami Monfared","year":"2022","unstructured":"Tahami Monfared AA, Byrnes MJ, White LA, Zhang Q. Alzheimer\u2019s Disease: Epidemiology and Clinical Progression. Neurol Ther. 2022;11:553\u201369.","journal-title":"Neurol Ther"},{"key":"6148_CR4","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/alz.13565","volume":"20","author":"V Devanarayan","year":"2023","unstructured":"Devanarayan V, Ye Y, Charil A, Andreozzi E, Sachdev P, Llano DA, et al. Predicting clinical progression trajectories of early Alzheimer\u2019s disease patients. Alzheimers Dement. 2023;20:1725\u201338.","journal-title":"Alzheimers Dement"},{"key":"6148_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1021\/acs.jproteome.9b00345","volume":"19","author":"A Vignoli","year":"2020","unstructured":"Vignoli A, Santini G, Tenori L, Macis G, Mores N, Macagno F, et al. NMR-Based metabolomics for the Assessment of Inhaled Pharmacotherapy in Chronic Obstructive Pulmonary Disease patients. J Proteome Res. 2020;19:64\u201374.","journal-title":"J Proteome Res"},{"key":"6148_CR6","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1002\/cncr.30829","volume":"123","author":"Y Long","year":"2017","unstructured":"Long Y, Sanchez-Espiridion B, Lin M, White L, Mishra L, Raju GS, et al. Global and targeted serum metabolic profiling of colorectal cancer progression. Cancer. 2017;123:4066\u201374.","journal-title":"Cancer"},{"key":"6148_CR7","doi-asserted-by":"publisher","first-page":"107678","DOI":"10.1016\/j.isci.2023.107678","volume":"26","author":"A Vignoli","year":"2023","unstructured":"Vignoli A, Miolo G, Tenori L, Buonadonna A, Lombardi D, Steffan A, et al. Novel metabolomics-biohumoral biomarkers model for predicting survival of metastatic soft-tissue sarcomas. iScience. 2023;26:107678.","journal-title":"iScience"},{"key":"6148_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1470-2045(09)70314-6","volume":"11","author":"KS Albain","year":"2010","unstructured":"Albain KS, Barlow WE, Shak S, Hortobagyi GN, Livingston RB, Yeh I-T, et al. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Lancet Oncol. 2010;11:55\u201365.","journal-title":"Lancet Oncol"},{"key":"6148_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41523-019-0123-9","volume":"5","author":"A McCartney","year":"2019","unstructured":"McCartney A, Vignoli A, Tenori L, Fornier M, Rossi L, Risi E, et al. Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification. NPJ Breast Cancer. 2019;5:26.","journal-title":"NPJ Breast Cancer"},{"key":"6148_CR10","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1038\/s41591-022-01980-3","volume":"28","author":"T Buergel","year":"2022","unstructured":"Buergel T, Steinfeldt J, Ruyoga G, Pietzner M, Bizzarri D, Vojinovic D, et al. Metabolomic profiles predict individual multidisease outcomes. Nat Med. 2022;28:2309\u201320.","journal-title":"Nat Med"},{"key":"6148_CR11","doi-asserted-by":"publisher","first-page":"1308500","DOI":"10.3389\/fmolb.2023.1308500","volume":"10","author":"A Vignoli","year":"2023","unstructured":"Vignoli A, Tenori L. NMR-based metabolomics in Alzheimer\u2019s disease research: a review. Front Mol Biosci. 2023;10:1308500.","journal-title":"Front Mol Biosci"},{"key":"6148_CR12","doi-asserted-by":"publisher","first-page":"101987","DOI":"10.1016\/j.arr.2023.101987","volume":"89","author":"S Lista","year":"2023","unstructured":"Lista S, Gonz\u00e1lez-Dom\u00ednguez R, L\u00f3pez-Ortiz S, Gonz\u00e1lez-Dom\u00ednguez \u00c1, Men\u00e9ndez H, Mart\u00edn-Hern\u00e1ndez J, et al. Integrative metabolomics science in Alzheimer\u2019s disease: relevance and future perspectives. Ageing Res Rev. 2023;89:101987.","journal-title":"Ageing Res Rev"},{"key":"6148_CR13","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1021\/acs.jproteome.9b00850","volume":"19","author":"A Vignoli","year":"2020","unstructured":"Vignoli A, Paciotti S, Tenori L, Eusebi P, Biscetti L, Chiasserini D, et al. Fingerprinting Alzheimer\u2019s disease by 1H nuclear magnetic resonance spectroscopy of Cerebrospinal Fluid. J Proteome Res. 2020;19:1696\u2013705.","journal-title":"J Proteome Res"},{"key":"6148_CR14","doi-asserted-by":"publisher","first-page":"1219718","DOI":"10.3389\/fnagi.2023.1219718","volume":"15","author":"Georgy Berezhnoy","year":"2025","unstructured":"Berezhnoy G, Laske C, Trautwein C. Metabolomic profiling of CSF and blood serum elucidates general and sex-specific patterns for mild cognitive impairment and Alzheimer\u2019s disease patients. Frontiers in Aging Neuroscience. 2023;15:1219718.","journal-title":"Front. Aging Neurosci."},{"key":"6148_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13195-023-01379-3","volume":"16","author":"Y-X Qiang","year":"2024","unstructured":"Qiang Y-X, You J, He X-Y, Guo Y, Deng Y-T, Gao P-Y, et al. Plasma metabolic profiles predict future dementia and dementia subtypes: a prospective analysis of 274,160 participants. Alzheimers Res Ther. 2024;16:16.","journal-title":"Alzheimers Res Ther"},{"key":"6148_CR16","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.dadm.2017.07.006","volume":"8","author":"FA de Leeuw","year":"2017","unstructured":"de Leeuw FA, Peeters CFW, Kester MI, Harms AC, Struys EA, Hankemeier T, et al. Blood-based metabolic signatures in Alzheimer\u2019s disease. Alzheimers Dement (Amst). 2017;8:196\u2013207.","journal-title":"Alzheimers Dement (Amst)"},{"key":"6148_CR17","doi-asserted-by":"crossref","unstructured":"J\u00e4\u00e4skel\u00e4inen O, Hall A, Tiainen M, van Gils M, L\u00f6tj\u00f6nen J, Kangas AJ et al. Metabolic profiles help discriminate mild cognitive impairment from Dementia Stage in Alzheimer\u2019s Disease. J Alzheimers Dis. 2020;74:277\u201386.","DOI":"10.3233\/JAD-191226"},{"key":"6148_CR18","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.3233\/JAD-210573","volume":"85","author":"N Massetti","year":"2022","unstructured":"Massetti N, Russo M, Franciotti R, Nardini D, Mandolini GM, Granzotto A, et al. A machine learning-based holistic Approach to predict the clinical course of patients within the Alzheimer\u2019s Disease Spectrum. J Alzheimers Dis. 2022;85:1639\u201355.","journal-title":"J Alzheimers Dis"},{"key":"6148_CR19","doi-asserted-by":"publisher","first-page":"647783","DOI":"10.3389\/fnins.2021.647783","volume":"15","author":"Giovanni Bellomo","year":"2021","unstructured":"Bellomo G, Indaco A, Chiasserini D, Maderna E, Paolini Paoletti F, Gaetani L et al. Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer\u2019s Disease and Other Neurological Disorders. Front Neurosci. 2021;15:647783.","journal-title":"Front. Neurosci."},{"key":"6148_CR20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack CR, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14:535\u201362.","journal-title":"Alzheimers Dement"},{"key":"6148_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.pnmrs.2023.10.002","volume":"138\u2013139","author":"V Ghini","year":"2023","unstructured":"Ghini V, Meoni G, Vignoli A, Di Cesare F, Tenori L, Turano P, et al. Fingerprinting and profiling in metabolomics of biosamples. Progress Nucl Magn Reson Spectrosc. 2023;138\u2013139:105\u201335.","journal-title":"Progress Nucl Magn Reson Spectrosc"},{"key":"6148_CR22","doi-asserted-by":"publisher","first-page":"6797","DOI":"10.1038\/s41598-024-56837-1","volume":"14","author":"T Oka","year":"2024","unstructured":"Oka T, Matsuzawa Y, Tsuneyoshi M, Nakamura Y, Aoshima K, Tsugawa H. Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer\u2019s Disease Neuroimaging Initiative cohort. Sci Rep. 2024;14:6797.","journal-title":"Sci Rep"},{"key":"6148_CR23","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1002\/elps.201400196","volume":"35","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2014","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda A, Garc\u00eda-Barrera T, Barbas C, G\u00f3mez-Ariza JL. Metabolomic profiling of serum in the progression of Alzheimer\u2019s disease by capillary electrophoresis\u2013mass spectrometry. Electrophoresis. 2014;35:3321\u201330.","journal-title":"Electrophoresis"},{"key":"6148_CR24","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00726-006-0409-8","volume":"32","author":"AN Fonteh","year":"2007","unstructured":"Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG. Free amino acid and dipeptide changes in the body fluids from Alzheimer\u2019s disease subjects. Amino Acids. 2007;32:213\u201324.","journal-title":"Amino Acids"},{"key":"6148_CR25","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fnagi.2019.00175","volume":"11","author":"X Pan","year":"2019","unstructured":"Pan X, Kaminga AC, Wen SW, Wu X, Acheampong K, Liu A. Dopamine and dopamine receptors in Alzheimer\u2019s Disease: a systematic review and network Meta-analysis. Front Aging Neurosci. 2019;11:175.","journal-title":"Front Aging Neurosci"},{"key":"6148_CR26","doi-asserted-by":"publisher","first-page":"14727","DOI":"10.1038\/ncomms14727","volume":"8","author":"A Nobili","year":"2017","unstructured":"Nobili A, Latagliata EC, Viscomi MT, Cavallucci V, Cutuli D, Giacovazzo G, et al. Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer\u2019s disease. Nat Commun. 2017;8:14727.","journal-title":"Nat Commun"},{"key":"6148_CR27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/jnr.10348","volume":"70","author":"K Yanagisawa","year":"2002","unstructured":"Yanagisawa K. Cholesterol and pathological processes in Alzheimer\u2019s disease. J Neurosci Res. 2002;70:361\u20136.","journal-title":"J Neurosci Res"},{"key":"6148_CR28","doi-asserted-by":"publisher","first-page":"e2088","DOI":"10.1212\/WNL.0000000000009436","volume":"94","author":"MM Bernath","year":"2020","unstructured":"Bernath MM, Bhattacharyya S, Nho K, Barupal DK, Fiehn O, Baillie R, et al. Serum triglycerides in Alzheimer disease. Neurology. 2020;94:e2088\u201398.","journal-title":"Neurology"},{"key":"6148_CR29","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/archneurol.2009.106","volume":"66","author":"ST Farias","year":"2009","unstructured":"Farias ST, Mungas D, Reed BR, Harvey D, DeCarli C. Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Arch Neurol. 2009;66:1151\u20137.","journal-title":"Arch Neurol"},{"key":"6148_CR30","doi-asserted-by":"publisher","first-page":"115815","DOI":"10.1016\/j.jpba.2023.115815","volume":"238","author":"R Conde","year":"2024","unstructured":"Conde R, Oliveira N, Morais E, Amaral AP, Sousa A, Gra\u00e7a G, et al. NMR analysis seeking for cognitive decline and dementia metabolic markers in plasma from aged individuals. J Pharm Biomed Anal. 2024;238:115815.","journal-title":"J Pharm Biomed Anal"},{"key":"6148_CR31","doi-asserted-by":"publisher","first-page":"e064860","DOI":"10.1002\/alz.064860","volume":"18","author":"X Arakaki","year":"2022","unstructured":"Arakaki X, Buennagel DP, Nolty A, Spezzaferri M, Rising S, Sin C, et al. Triglyceride and VLDL cholesterol are lower in cognitively healthy individuals with amyloid pathologies than those without. Alzheimer\u2019s Dement. 2022;18:e064860.","journal-title":"Alzheimer\u2019s Dement"},{"key":"6148_CR32","first-page":"330","volume":"4","author":"J Cummings","year":"2018","unstructured":"Cummings J, Reiber C, Kumar P. The price of progress: funding and financing Alzheimer\u2019s disease drug development. Alzheimer\u2019s Dementia: Translational Res Clin Interventions. 2018;4:330\u201343.","journal-title":"Alzheimer\u2019s Dementia: Translational Res Clin Interventions"},{"key":"6148_CR33","doi-asserted-by":"publisher","first-page":"e2673","DOI":"10.1212\/WNL.0000000000012022","volume":"96","author":"RJ Jutten","year":"2021","unstructured":"Jutten RJ, Sikkes SAM, Van der Flier WM, Scheltens P, Visser PJ, Tijms BM, et al. Finding Treatment effects in Alzheimer trials in the Face of Disease Progression Heterogeneity. Neurology. 2021;96:e2673\u201384.","journal-title":"Neurology"},{"key":"6148_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s13311-022-01185-z","volume":"19","author":"R Duara","year":"2022","unstructured":"Duara R, Barker W. Heterogeneity in Alzheimer\u2019s Disease diagnosis and progression rates: implications for therapeutic trials. Neurotherapeutics. 2022;19:8\u201325.","journal-title":"Neurotherapeutics"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06148-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06148-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06148-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T13:38:43Z","timestamp":1737985123000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06148-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6148"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06148-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"assertion":[{"value":"14 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study has received the approval from the local Ethics Committee (Comitato Etico Aziende Sanitarie Regione Umbria 19369\/AV and 20942\/21\/OV), and all patients and\/or their legal representatives gave informed written consent to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted without any commercial or financial relationships that could be construed as potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"119"}}